Daily Chemical News Recommendation ( Sept. 25 2018)

ECHEMI will recommend you several daily chemical news. If you want to know more, please go to our News Section.

>>Scientists discover drug target for neurodegenerative diseases and cancer

A team of scientists at the Institute of Life Sciences (ILS), led by Dr. Santosh Chuahan, have identified a drug target for neurodegenerative diseases and cancer.

Accumulation of protein aggregates is a hallmark of neurodegenerative diseases. For therapeutic interventions in the case of neurodegenerative diseases, it is important to understand the mechanism involved in the formation and degradation of protein aggregates.  [More] 

 >>Sun Pharma gets regulatory observations from USFDA

Sun Pharma has got six regulatory observations on its Halol factory in Gujarat from the US Food and Drug Administration (FDA), the company said, adding that it would respond in two weeks.

“The USFDA conducted a pre-approval inspection (PAI) of Sun Pharmaceutical Industries’ Halol facility from August 27, 2018 to August 31, 2018,” the company said, adding that the inspection concluded with the regulator issuing a Form 483 with six observations. The company, however, did not provide details about the observations issued.[More]